Gil Savir
Lawyers
Associate in our Capital Markets practice.
Gil advises U.S., European and Israeli issuers on various fundraising activities, including initial public offerings, other equity offerings, and public and private investment-grade and convertible debt offerings. He also advises clients ranging from early-stage privately held companies to well-known seasoned issuers on governance, SEC reporting, strategic transactions and other corporate law matters. His practice ranges across a verity of industries, including deep-tech, cybersecurity, biotech, fintech and consumer and retail.
Experience highlights
Recent Representations
- MGP Ingredients $201.25 million convertible senior notes offering
- Crown Proptech Acquisitions $808 million merger with Brivo
- Compass Digital Acquisition $200 million IPO
- Decarbonization Plus Acquisition Corporation IV $275 million IPO
- Cyteir Therapeutics $133.2 million IPO
- Molecular Partners $64 million IPO
- Nayax ILS 767 million IPO
- Decarbonization Plus Acquisition Corporation III $350 million IPO
- Paya Holdings $245 million stock offering
- Kadem Sustainable Impact $175 million IPO
- Crown PropTech Acquisitions $276 million IPO
- Decarbonization Plus Acquisition Corporation II $402.5 million IPO
- CureVac $450 million public offering
- Perion Network $66 million follow-on offering
- Star Peak II $350 million IPO
- Range Resources $600 million senior notes offering
Education
S.J.D., University of Michigan Law School
- Michigan Grotius Fellowship
- Phi Kappa Phi
- Scholarly Writing Award
LL.M., Taxation, University of Michigan Law School
- Phi Kappa Phi
LL.B., College of Management, Haim Striks School of Law
Professional history
- Davis Polk since 2015
Qualifications and admissions
- Israel Bar
- State of New York